UCSF Innovation Ventures Engagement & Opportunity Development and Licensing Teams organized and hosted a panel discussion entitled “Translating UCSF research into human therapeutics. Minutia: Shifting the T1D Paradigm on October 23, 2024. Darya Bubman moderated a conversation with the founders of Minutia, a next-generation cell therapy company, and a UCSF spinout, about the experience of working to move academic research into a start-up environment and how the process can be different for a predominantly female team.
Big thanks to Cathy Smith, PhD, Senior Manager, Business Development and Licensing; Darya Bubman, PhD, Assistant Director of BD & EOD; Todd Pazdera, PhD, Director of EOD & Licensing and David Morris, MD, Vice Chancellor of Innovation Ventures.
You can watch the panel here: